Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1959 1
1961 2
1962 1
1963 2
1964 4
1965 1
1966 1
1967 4
1968 2
1969 5
1970 7
1971 1
1972 3
1973 4
1974 2
1975 3
1976 7
1977 7
1978 9
1979 13
1980 4
1981 15
1982 13
1983 4
1984 11
1985 18
1986 14
1987 15
1988 14
1989 21
1990 14
1991 26
1992 21
1993 15
1994 23
1995 18
1996 15
1997 11
1998 16
1999 32
2000 27
2001 30
2002 32
2003 41
2004 46
2005 57
2006 57
2007 63
2008 46
2009 61
2010 54
2011 84
2012 85
2013 93
2014 100
2015 75
2016 93
2017 100
2018 89
2019 112
2020 133
2021 142
2022 82
Text availability
Article attribute
Article type
Publication date

Search Results

1,897 results
Results by year
Filters applied: . Clear all
Page 1
Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial.
Packer M, Anker SD, Butler J, Filippatos G, Ferreira JP, Pocock SJ, Sattar N, Brueckmann M, Jamal W, Cotton D, Iwata T, Zannad F; EMPEROR-Reduced Trial Committees and Investigators. Packer M, et al. Among authors: iwata t. J Am Coll Cardiol. 2021 Mar 23;77(11):1381-1392. doi: 10.1016/j.jacc.2021.01.033. J Am Coll Cardiol. 2021. PMID: 33736819 Free article. Clinical Trial.
Histamine-releasing factor enhances food allergy.
Ando T, Kashiwakura JI, Itoh-Nagato N, Yamashita H, Baba M, Kawakami Y, Tsai SH, Inagaki N, Takeda K, Iwata T, Shimojo N, Fujisawa T, Nagao M, Matsumoto K, Kawakami Y, Kawakami T. Ando T, et al. Among authors: iwata t. J Clin Invest. 2017 Dec 1;127(12):4541-4553. doi: 10.1172/JCI96525. Epub 2017 Nov 13. J Clin Invest. 2017. PMID: 29130935 Free PMC article. Clinical Trial.
Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial.
Packer M, Anker SD, Butler J, Filippatos G, Ferreira JP, Pocock SJ, Rocca HB, Janssens S, Tsutsui H, Zhang J, Brueckmann M, Jamal W, Cotton D, Iwata T, Schnee J, Zannad F; EMPEROR-Reduced Trial Committees and Investigators. Packer M, et al. Among authors: iwata t. Eur Heart J. 2021 Feb 11;42(6):671-680. doi: 10.1093/eurheartj/ehaa968. Eur Heart J. 2021. PMID: 33459776 Free PMC article. Clinical Trial.
Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial.
Januzzi JL Jr, Zannad F, Anker SD, Butler J, Filippatos G, Pocock SJ, Ferreira JP, Sattar N, Verma S, Vedin O, Schnee J, Iwata T, Cotton D, Packer M; EMPEROR-Reduced Trial Committees and Investigators. Januzzi JL Jr, et al. Among authors: iwata t. J Am Coll Cardiol. 2021 Sep 28;78(13):1321-1332. doi: 10.1016/j.jacc.2021.07.046. J Am Coll Cardiol. 2021. PMID: 34556318 Free article. Clinical Trial.
Reply by Authors.
Tafuri A, Iwata A, Shakir A, Iwata T, Gupta C, Sali A, Sugano D, Mahdi AS, Cacciamani GE, Kaneko M, Cai J, Ukimura O, Duddalwar V, Aron M, Gill IS, Palmer SL, Abreu AL. Tafuri A, et al. Among authors: iwata t. J Urol. 2021 Aug;206(2):297. doi: 10.1097/JU.0000000000001766.02. Epub 2021 Jul 2. J Urol. 2021. PMID: 34235960 No abstract available.
Reply by Authors.
Tafuri A, Iwata A, Shakir A, Iwata T, Gupta C, Sali A, Sugano D, Mahdi AS, Cacciamani GE, Kaneko M, Cai J, Ukimura O, Duddalwar V, Aron M, Gill IS, Palmer SL, Abreu AL. Tafuri A, et al. Among authors: iwata t. J Urol. 2021 Aug;206(2):426. doi: 10.1097/JU.0000000000001792.03. Epub 2021 Jun 1. J Urol. 2021. PMID: 34060336 No abstract available.
1,897 results